In The News,
Lindsay Bealor Greenleaf Featured in Specialty Pharmacy Times
LINDSAY BEALOR GREENLEAF FEATURED IN SPECIALTY PHARMACY TIMES
Written by Laurie Toich
Thursday, 9 March 2017
“When we talk about supply chain, we have to acknowledge the distortions that are in the marketplace. We had a recent Berkley Research Group study showing that manufacturers are retaining less than half of all spending on prescription drugs,” Lindsay Bealor Greenleaf, director at ADVI Health told Specialty Pharmacy Times. “We also had a recent CMS report showing that DIR fees are growing much faster than Part D costs. So, we’re starting off with a distorted marketplace. The biggest issue is patients aren’t really benefitting as much from this process as people might think.”